EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in Farmington and Branford, CT.  Building upon research that originates from the Sidi Chen Lab at Yale University, EvolveImmune is leveraging a novel in vivo target discovery platform to develop a broad portfolio of first-in-class molecules for unmet needs in oncology and autoimmune diseases.

Biotechnology

EvolveImmune Therapeutics

Stephen Bloch

Michael Franken M.D.

Charles Fuchs

Jennifer Gabler

Louis Matis

The Leadership Team at EvolveImmune Therapeutics is responsible for setting the strategic direction of the company, overseeing the development and commercialization of innovative immunotherapy solutions. This diverse group of founders and executives collaborates to align research initiatives with market needs, secure funding, and navigate regulatory landscapes, ensuring the advancement of cutting-edge treatments addressing critical challenges in oncology and autoimmune diseases.

Leadership Team

Research and Development

Directors and Senior Management

Leadership Team

About

Team members

Other teams at EvolveImmune Therapeutics

Research and Development

Directors and Senior Management